some into some our items our I'm the statements to Howard. briefly some going performance also and second in now as you, material some will provide of as quarter review I financial to further items. believe well that highlight metrics quarter second explanation what attempt to I Thank insights be certain our drove give XXXX of performance.
I XXXX update depreciation use the Medicare guidance financial financial reimbursement measure. and my for will adjusted non-GAAP Adjusted levels XXXX. discussion, defines discuss will I a EBITDA, is company Lastly, which The term earnings In purchase before compensation. bargain or taxes, equity disposal debt gains as interest and on on other equipment non-cash amortization loss, income or losses of gains and EBITDA the extinguishments, excludes loss and
included of extraordinary and earnings, RadNet to income period. to subsidiaries unconsolidated of non-cash, to loss net full in non-controlling earnings includes and adjusted the equity A or attributable subtracts in place adjusted allocations interests common one-time our quantitative taken EBITDA is shareholders and operations earnings earnings reconciliation is Adjusted in Inc. for during events EBITDA release. or
I'd that With XXXX review our quarter to like now said, second results.
reported XXXX, quarter. million, XX% EBITDA Revenue million, same EBITDA prior ended increased over three million June XX, year and the year $XXX.X RadNet XX.X% quarter, of million. adjusted or of same For increased prior revenue months over $XX.X the the $XX.X adjusted and $X or
increased For exams volume MRI as X%. X.X%, volume prior mammography, XX.X% prior into and the exams other quarter the all year's to account X-ray, XX.X%, second taking compared routine increased increased second second and XXXX, Overall, imaging year's PET/CT inclusive CT over quarter. of the of volume ultrasound, quarter increased volume
The we the imaging. of performed did by were approach procedures second in quarter with XX% XXXX, routine whereby work volume of the quarter we second multimodality XXX,XXX was our consistent procedures. all the total In from
second XXX,XXX were quarter MRIs follows. with compared Our of procedures routine with quarter the as the XXX,XXX quarter quarter in in and of in XX,XXX imaging with as compared routine PET/CT CTs CTs quarter XXXX. the the the of exams X,XXX second compared as with second XXXX XXXX. second compared PET/CTs XXX,XXX of in second XXXX. as in exams MRI's of as X,XXX,XXX XXX,XXX X,XXX,XXX XXXX
quarter second XX.X approximately income the settlements was quarter the $XXX,XXX $X.X compared second quarter quarter, $X.XX an over of during second million of number $X.X million For upon legal a quarter XXXX. financing million of quarter of RadNet second for of tax basis increase XXXX second per and of expenses of of diluted for Adjusting $XXX,XXX $XXX,XXX accounted the share share the was the the in in for million in in shares of XXXX, other quarter income of XXXX. the average net and XXXX. the net on a the transaction over $X.XX effective shares decrease net second reported, outstanding adjusted in diluted weighted shares Per to based XX.X a impact income
impact in this the second transaction settlements share for the the XXXX. legal $X.XX quarter second per for and to income diluted financing adjusted quarter expenses of accounted compared of $X.XX Adjusting other year net in the the of in was
Affecting million from stock. employee and non-recurring including income the following, certain of expenses certain quarter XXXX resulting in net vesting $X stock expense compensation the of non-cash the and were second non-cash options restricted of items
deferred savings headcount with and and sale initiatives related on loan $XXX,XXX of and legal connection settlements, in related capital issuances. $X.X reductions debt transaction financing paid cost equipment of $XXX,XXX million loss and financing certain severance non-cash -- the to on expenses to other the of of costs of certain on discounts amortization $XXX,XXX
was of Cash This is NJIN, million. last interest million term The as of and the of interest and in own the debt expense the $X.X increased Overall GAAP interest paid excludes increased interest XXXX to accrued XXXX GAAP of which second $XX.X compared interest the financing expense quarter quarter during second for facility. the has expenses second was for with credit year. quarter, compares its which of of the expense loan result million. deferred $XX non-cash million consolidation quarter in $XX.X
our At approximately borrower cash less par of term now Note $XX.X had June $XXX.X had debt is At which XXXX, were revolving our neither undrawn a debt, includes RadNet of June XX, $XXX.X million a of at we our cash a $XX.X the million guarantor. value we XXXX, net million. of for on nor credit line and balance par million XX is debt of adjusting for value which loan, that balance. value total this NJIN net the
the expenditures term of and XXXX, XX, of and asset quarter, notes December and $XX.X million. receivable accounts repaid increased During we $XX.X net million capital debt Since dispositions million DSOs leases our of revenue payable decrease $XX.X our days had sales approximately And due day in were acquisitions. growth approximately net year-end XX.X a since from X.X to days and the new of XXXX. outstanding or loan
I'd guidance year quarter time, results in quarter like this levels, to first financial At our which results. end conjunction with fourth XXXX after our released year amended and fiscal we update XXXX our an
we net total For end increased million. of top our and this revenue, levels by the end quarter both guidance the bottom $XX
is So billion. new billion $X.X our $X.XXX range or guidance revised to guidance
of by million. EBITDA, top adjusted end of our range we increased our end range the For the bottom and $X
free million million, $XX so $XXX to also So million. million, new and our million We've expenditures generation we kept the range $XX $X well cash interest range cash guidance $XX levels million. guidance capital our to our leave at $XX new $XXX to chosen at $XX as same is expense we've by our to guidance increased flow million million range to is as our million $XX constant
financial EBITDA. from The to our optimistic increase recent are and The XXXX and these full first acquisitions and organic growth XXXX revenue contribution of the We projections initial far. continuation adjusted provided has performance causing ranges health to end year about us guidance consistent us second trends XXXX. for of and the our remain and system confidence the the joint through into quarters of year the thus ventures the exceed strong
to about by update which respect Medicare on know recently a matrix an what give typical we released regards to Medicare year. part that every reimbursement anticipated is as minutes take XXXX Fee Schedule CPT you we rates Physician XXXX to a proposal discuss time few now and is rates. I'll code, of with With for this received the proposed reimbursement,
compared We those XXXX have to procedure and volume We rates weighted XXXX completed volumes. an analysis expected initial our analysis rates. using
rates Medicare analysis be shows neutral initial essentially that Our relative rates. will to XXXX our for XXXX
While there Incentive has impact. year been our performance pricing, MIPS, our upon mitigates of XXXX Payment is based fully from which a small XXXX impact negative under bonus System in measurement this Merit-based
of quality you required who and are a MIPS, by to less rewards is CMS program with incentive those value outcomes. familiar law payment For which implement
performance us impact. under have quality, a bonus for poor cost. Performance MIPS a measured activities, areas; four XXXX is in in was improvement excellent, providing promoting whereas could resulted and interoperability reimbursement a RadNet's reimbursement, negative performance
obviously very outcome, are reimbursement has pleased has been with past. as reimbursement We time the at challenged in the
course, to reflect lobbying for schedule there subject proposed the groups assurance rates be industry the Of fee no proposed the November to rates. timeframe the in these rule financial from released and are XXXX will the comment and physician is same
to through rates, final rule continue ability the lowering consistent not or and we in be drive focused efficiencies will to the in timeframe proposed cost November on our structure Whether is organization. our with our scale using
we are compared in increases recognizing our prices We hospital regions remain as where that to essential significantly payers to healthcare delivery from system, pricing discounted settings. to continue private seek will the
to long-term these continue result increased arrangements pursue systems where with volumes pricing payers. from in could think stable also partnership private will health We and opportunities we
we will efficiencies existing acquire three five in markets our Lastly, in our at operations. that and geographies targets local to times our achieve further times strategic continue to core with strength EBITDA
make who'll some the Dr. I'd call closing to now over Berger, turn to back like remarks.